Global Oral Rehydration Salts (ORS) Market Size By Type (Solutions, Powders), By Application (Infants, Children), By Region, And Segment Forecasts, 2023 to 2032

The Global Oral Rehydration Salts (ORS) Market was valued at USD 832 million in 2023 and is projected to reach USD 1.41 billion by 2031, growing at a CAGR of 6.8% during the forecast period from 2023 to 2031. The market is witnessing robust growth due to the increasing prevalence of diarrhea-related illnesses, rising awareness about dehydration treatments, and widespread adoption of ORS in both medical and home-care settings. ORS plays a vital role in replenishing lost fluids and electrolytes, especially in children and elderly populations, positioning it as a cornerstone of primary healthcare in both developing and developed regions.

Drivers:

1. Growing Incidence of Diarrheal Diseases:

Diarrhea remains a leading cause of morbidity and mortality among children under five, especially in low- and middle-income countries. The affordability, ease of use, and proven efficacy of ORS make it a critical intervention.

2. WHO and UNICEF Endorsements:

Endorsements and guidelines from major health organizations, such as WHO and UNICEF, promoting ORS usage in diarrhea treatment are significantly propelling market demand, especially in under-resourced healthcare systems.

3. Public Health Campaigns:

Government and non-governmental initiatives to promote awareness about ORS usage in rural and semi-urban areas are significantly boosting product penetration.

Restraints:

1. Lack of Access and Distribution Challenges:

Remote areas in developing regions often face shortages and inconsistent distribution of ORS, affecting overall accessibility and market growth.

2. Preference for Intravenous Therapy in Severe Cases:

In severe dehydration or hospital settings, the preference for intravenous rehydration limits ORS usage, particularly in critical care scenarios.

Opportunity:

1. Innovative Formulations and Flavored ORS Products:

The development of flavored, sugar-free, and zinc-supplemented ORS formulations targeted at children and athletes is unlocking new consumer segments.

2. E-commerce and Retail Pharmacy Expansion:

The growth of online pharmacies and organized retail chains is improving consumer access to ORS, creating a significant opportunity for product reach and brand differentiation.

Market by System Type Insights:

The Powder-based ORS segment dominated the market in 2023, attributed to its longer shelf-life, cost-effectiveness, and widespread acceptance. However, the Ready-to-Drink (RTD) ORS segment is projected to witness the fastest growth during the forecast period due to convenience, especially in urban and travel settings.

Market by End-use Insights:

In terms of end-use, the Pediatric segment held the largest share in 2023, driven by high vulnerability of children to diarrheal diseases and dehydration. The Adult segment, particularly in the sports and fitness industry, is expected to show substantial growth due to increased awareness of hydration during physical activity.

Market by Regional Insights:

Asia-Pacific emerged as the leading region in 2023, primarily driven by large population bases, high burden of diarrheal diseases, and strong governmental public health programs. Africa is expected to experience the fastest CAGR, supported by increased donor funding, healthcare access initiatives, and rising ORS awareness campaigns.

Competitive Scenario:

Key players in the Global ORS Market include FDC Limited, Abbott Laboratories, GlaxoSmithKline plc, Cipla Inc., Sanofi, Otsuka Pharmaceutical Co., Ltd., Prestige Brands Inc., and Trifecta Pharmaceuticals. These companies are focusing on geographical expansion, innovation in flavor and packaging, and partnerships with public health organizations to broaden their market presence.

Key Developments:

In 2024, Abbott launched a zinc-fortified ORS sachet line aimed at reducing childhood dehydration in India and Southeast Asia.

GSK entered a partnership with UNICEF in 2023 to distribute flavored ORS in Sub-Saharan Africa.

Prestige Brands expanded its distribution network to Latin America in 2025, focusing on urban pharmacy chains.

Scope of Work – Global Oral Rehydration Salts (ORS) Market

FAQs

1) What is the current market size of the Global Oral Rehydration Salts (ORS) Market?

The market was valued at USD 832 million in 2023.

2) What is the major growth driver of the Global Oral Rehydration Salts (ORS) Market?

The primary growth driver is the increasing prevalence of diarrheal diseases and global awareness campaigns promoting ORS usage.

3) Which is the largest region during the forecast period in the Global Oral Rehydration Salts (ORS) Market?

Asia-Pacific held the largest market share and is expected to maintain its lead.

4) Which segment accounted for the largest market share in the Global Oral Rehydration Salts (ORS) Market?

The Powder-based ORS segment held the dominant share in 2023.

5) Who are the key market players in the Global Oral Rehydration Salts (ORS) Market?

Leading companies include FDC Limited, Abbott Laboratories, GlaxoSmithKline plc, Cipla Inc., Sanofi, and others.